Beyond Air Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Public

  • Employees
  • 107

Employees

  • Stock Symbol
  • XAIR

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $0.20
  • (As of Wednesday Closing)

Beyond Air General Information

Description

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

Contact Information

Formerly Known As
Advanced Inhalation Therapies, Ait Therapeutics, Inc.
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 900 Stewart Avenue
  • Suite 301
  • Garden City, NY 11530
  • United States
+1 (516)
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 900 Stewart Avenue
  • Suite 301
  • Garden City, NY 11530
  • United States
+1 (516)

Beyond Air Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Beyond Air Stock Performance

As of 18-Jun-2025, Beyond Air’s stock price is $0.20. Its current market cap is $17.5M with 86.4M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.20 $0.28 $0.16 - $1.49 $17.5M 86.4M 2.68M -$0.69

Beyond Air Financials Summary

As of 31-Mar-2025, Beyond Air has a trailing 12-month revenue of $3.71M.

In Thousands,
USD
TTM 31-Mar-2025 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024 FY 2023 31-Mar-2023
EV 15,852 15,852 68,191 157,322
Revenue 3,705 3,705 1,159 0
EBITDA (59,031) (58,201)
Net Income (46,625) (46,625) (60,242) (55,816)
Total Assets 30,062 30,062 56,961 68,749
Total Debt 11,688 11,688 17,837 3,592
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Beyond Air Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Beyond Air‘s full profile, request access.

Request a free trial

Beyond Air Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Gene
Therapeutic Devices
Garden City, NY
107 As of 2024

Langhorne, PA
 

Atlanta, GA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Beyond Air Competitors (8)

One of Beyond Air’s 8 competitors is Savara, a Formerly VC-backed company based in Langhorne, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Savara Formerly VC-backed Langhorne, PA
VERO Biotech Private Equity-Backed Atlanta, GA
Bedfont Corporation Maidstone, United Kingdom
Respira Therapeutics Venture Capital-Backed Palo Alto, CA
Pulmatrix Formerly VC-backed Framingham, MA
You’re viewing 5 of 8 competitors. Get the full list »

Beyond Air Patents

Beyond Air Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023302931-A1 Cancer treatment using ultra-high concentration gaseous nitric oxide and a checkpoint inhibitor Pending 06-Jul-2022
EP-4551233-A1 Cancer treatment using ultra-high concentration gaseous nitric oxide and a checkpoint inhibitor Pending 06-Jul-2022
AU-2023231103-A1 Methods of selecting treatment for cancer Pending 07-Mar-2022
EP-4489764-A1 Methods of selecting treatment for cancer Pending 07-Mar-2022
AU-2022282869-A1 Methods of producing tumor vaccines and uses thereof Pending 26-May-2021 A61K40/10
To view Beyond Air’s complete patent history, request access »

Beyond Air Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Beyond Air Acquisitions (2)

Beyond Air’s most recent deal was a Merger/Acquisition with KokiCare. The deal was made on 13-Jan-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
KokiCare 13-Jan-2017 Merger/Acquisition Social/Platform Software
CSM (Saint-Maximin Factory) 17-Jul-2008 Merger/Acquisition Food Products
To view Beyond Air’s complete acquisitions history, request access »

Beyond Air ESG

Risk Overview

Risk Rating

Updated April, 26, 2025

29.32 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,673

Rank

Percentile

Software & Services

Industry

of 941

Rank

Percentile

Enterprise and Infrastructure Software

Subindustry

of 375

Rank

Percentile

To view Beyond Air’s complete esg history, request access »

Beyond Air FAQs

  • When was Beyond Air founded?

    Beyond Air was founded in 2011.

  • Where is Beyond Air headquartered?

    Beyond Air is headquartered in Garden City, NY.

  • What is the size of Beyond Air?

    Beyond Air has 107 total employees.

  • What industry is Beyond Air in?

    Beyond Air’s primary industry is Therapeutic Devices.

  • Is Beyond Air a private or public company?

    Beyond Air is a Public company.

  • What is Beyond Air’s stock symbol?

    The ticker symbol for Beyond Air is XAIR.

  • What is the current stock price of Beyond Air?

    As of 18-Jun-2025 the stock price of Beyond Air is $0.20.

  • What is the current market cap of Beyond Air?

    The current market capitalization of Beyond Air is $17.5M.

  • What is Beyond Air’s current revenue?

    The trailing twelve month revenue for Beyond Air is $3.71M.

  • Who are Beyond Air’s competitors?

    Savara, VERO Biotech, Bedfont, Respira Therapeutics, and Pulmatrix are some of the 8 competitors of Beyond Air.

  • What is Beyond Air’s annual earnings per share (EPS)?

    Beyond Air’s EPS for 12 months was -$0.69.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »